Pilot Study to Assess Number of Patients for Main Trial

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions

Wound Healing

Interventions

DRUG

Dexpanthenol (Bepanthen® Wund- und Heilsalbe, BAY81-2996)

30 g of 5% of the active ingredient dexpanthenol plus other ingredients as ointment

DRUG

Placebo

Placebo to Bepanthen® ointment without active ingredient dexpanthenol

Trial Locations (1)

Hamburg